1995
DOI: 10.1016/s0042-6822(95)80019-0
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional inhibition of the parvovirus minute virus of mice by constitutive expression of an antisense RNA targeted against the NS-1 transactivator protein

Abstract: We have assessed a genetic resistance approach based on antisense RNA to interfere with the prototype Minute Virus of Mice (MVMp), an autonomous parvovirus. MVMp is a cytolytic virus when infecting the permissive A9 mouse fibroblast cell line, and its gene expression is largely regulated at the level of transcription initiation by the nonstructural transactivator NS-1 protein, a multifunctional polypeptide also involved in viral DNA replication and cytotoxicity. An NS-1 specific antisense RNA constitutively ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
24
0

Year Published

1997
1997
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(24 citation statements)
references
References 53 publications
0
24
0
Order By: Relevance
“…Site-directed mutagenesis of the VP1/ VP2 gene of MVM (strain p) was carried out using the QuikChange system (Stratagene) on recombinant plasmid pSVtk-VP1/2 originally provided by J. M. Almendral (Centro de Biología Molecular, Madrid, Spain) (45). The mutations were introduced by subcloning in an MVMp infectious clone originally provided by P. Tattersall (Yale University Medical School, New Haven, CT) (46) and then modified (45). The presence of the mutations was confirmed by sequencing.…”
Section: Methodsmentioning
confidence: 99%
“…Site-directed mutagenesis of the VP1/ VP2 gene of MVM (strain p) was carried out using the QuikChange system (Stratagene) on recombinant plasmid pSVtk-VP1/2 originally provided by J. M. Almendral (Centro de Biología Molecular, Madrid, Spain) (45). The mutations were introduced by subcloning in an MVMp infectious clone originally provided by P. Tattersall (Yale University Medical School, New Haven, CT) (46) and then modified (45). The presence of the mutations was confirmed by sequencing.…”
Section: Methodsmentioning
confidence: 99%
“…Site-directed mutagenesis of the VP2 gene of MVM strain p (MVMp) was carried out by using the QuikChange system (Stratagene) on recombinant plasmids pSVtk-VP1͞2 [which included the VP1͞VP2 gene of MVMp and was derived from a molecular clone of the MVMp genome (46)] and pFB1-VP2 (47). The mutations were confirmed by automated sequencing.…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant Plasmids-Plasmid pSVTK-VP1/VP2 included the VP1/VP2 gene of MVMp and was derived from a molecular clone of the MVMp genome (51). The VP2-coding segment was amplified, using PCR and oligonucleotides with flanking BamHI and XhoI sites.…”
Section: Methodsmentioning
confidence: 99%